These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29548882)

  • 21. Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects.
    Greenfield JR; Farooqi IS; Keogh JM; Henning E; Habib AM; Blackwood A; Reimann F; Holst JJ; Gribble FM
    Am J Clin Nutr; 2009 Jan; 89(1):106-113. PubMed ID: 19056578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding.
    Korner J; Bessler M; Inabnet W; Taveras C; Holst JJ
    Surg Obes Relat Dis; 2007; 3(6):597-601. PubMed ID: 17936091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes.
    Rohde U; Federspiel CA; Vilmann P; Langholz E; Friis SU; Krakauer M; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    Diabetes Obes Metab; 2017 Feb; 19(2):189-199. PubMed ID: 27696668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Importance of Endogenously Secreted GLP-1 and GIP for Postprandial Glucose Tolerance and β-Cell Function After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy Surgery.
    Hindsø M; Hedbäck N; Svane MS; Møller A; Martinussen C; Jørgensen NB; Dirksen C; Gasbjerg LS; Kristiansen VB; Hartmann B; Rosenkilde MM; Holst JJ; Madsbad S; Bojsen-Møller KN
    Diabetes; 2023 Mar; 72(3):336-347. PubMed ID: 36478039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass.
    Tharakan G; Behary P; Wewer Albrechtsen NJ; Chahal H; Kenkre J; Miras AD; Ahmed AR; Holst JJ; Bloom SR; Tan T
    Eur J Endocrinol; 2017 Dec; 177(6):455-464. PubMed ID: 28855269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered glucose metabolism after bariatric surgery: What's GLP-1 got to do with it?
    Smith EP; Polanco G; Yaqub A; Salehi M
    Metabolism; 2018 Jun; 83():159-166. PubMed ID: 29113813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Appetite, Glycemia, and Entero-Insular Hormone Responses Differ Between Oral, Gastric-Remnant, and Duodenal Administration of a Mixed-Meal Test After Roux-en-Y Gastric Bypass.
    Gero D; Steinert RE; Hosa H; Cummings DE; Bueter M
    Diabetes Care; 2018 Jun; 41(6):1295-1298. PubMed ID: 29636353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastrointestinal Hormones and β-Cell Function After Gastric Bypass and Sleeve Gastrectomy: A Randomized Controlled Trial (Oseberg).
    Fatima F; Hjelmesæth J; Birkeland KI; Gulseth HL; Hertel JK; Svanevik M; Sandbu R; Småstuen MC; Hartmann B; Holst JJ; Hofsø D
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e756-e766. PubMed ID: 34463768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Responses of gut and pancreatic hormones, bile acids, and fibroblast growth factor-21 differ to glucose, protein, and fat ingestion after gastric bypass surgery.
    Jensen CZ; Bojsen-Møller KN; Svane MS; Holst LM; Hermansen K; Hartmann B; Wewer Albrechtsen NJ; Kuhre RE; Kristiansen VB; Rehfeld JF; Clausen TR; Holst JJ; Madsbad S
    Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G661-G672. PubMed ID: 32068442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Counter-regulatory responses to postprandial hypoglycaemia in patients with post-bariatric hypoglycaemia vs surgical and non-surgical control individuals.
    Tripyla A; Herzig D; Reverter-Branchat G; Pavan J; Schiavon M; Eugster PJ; Grouzmann E; Nakas CT; Sauvinet V; Meiller L; Zehetner J; Giachino D; Nett P; Gawinecka J; Del Favero S; Thomas A; Thevis M; Dalla Man C; Bally L
    Diabetologia; 2023 Apr; 66(4):741-753. PubMed ID: 36648553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects.
    Romero F; Nicolau J; Flores L; Casamitjana R; Ibarzabal A; Lacy A; Vidal J
    Surg Endosc; 2012 Aug; 26(8):2231-9. PubMed ID: 22302537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term glucose metabolism and gut hormone modulations after Billroth II gastrojejunostomy in nonobese gastric cancer patients with type 2 diabetes mellitus, impaired glucose tolerance and normal glucose tolerance.
    Zhang XJ; Xiao Z; Yu HL; Zhang XX; Cheng Z; Tian HM
    Arch Med Res; 2013 Aug; 44(6):437-43. PubMed ID: 23973197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr
    Patel A; Yusta B; Matthews D; Charron MJ; Seeley RJ; Drucker DJ
    Mol Metab; 2018 Oct; 16():45-54. PubMed ID: 29937214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the different biliopancreatic limb length on diabetes and incretin hormone secretion following distal gastrectomy in gastric cancer patients.
    Park JY; Kwon OK; Jeon JH; Choi YK; Park KB
    Sci Rep; 2021 Nov; 11(1):22451. PubMed ID: 34789863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of surgical control of type 2 diabetes: GLP-1 is the key factor-Maybe.
    Salehi M; D'Alessio DA
    Surg Obes Relat Dis; 2016 Jul; 12(6):1230-5. PubMed ID: 27568473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal.
    Berggren J; Lindqvist A; Hedenbro J; Groop L; Wierup N
    Surg Obes Relat Dis; 2017 Feb; 13(2):234-242. PubMed ID: 27894746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
    Rohde U
    Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass.
    Salehi M; Gastaldelli A; D'Alessio DA
    Gastroenterology; 2014 Mar; 146(3):669-680.e2. PubMed ID: 24315990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating Intestinal Glucagon After Roux-en-Y Gastric Bypass Surgery.
    Jorsal T; Wewer Albrechtsen NJ; Christensen MM; Mortensen B; Wandall E; Langholz E; Friis S; Worm D; Ørskov C; Støving RK; Andries A; Juhl CB; Sørensen F; Forman JL; Falkenhahn M; Musholt PB; Theis S; Larsen PJ; Holst JJ; Vrang N; Jelsing J; Vilsbøll T; Knop FK
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6403-6416. PubMed ID: 31276156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes.
    Rhee NA; Wahlgren CD; Pedersen J; Mortensen B; Langholz E; Wandall EP; Friis SU; Vilmann P; Paulsen SJ; Kristiansen VB; Jelsing J; Dalbøge LS; Poulsen SS; Holst JJ; Vilsbøll T; Knop FK
    Diabetologia; 2015 Oct; 58(10):2254-8. PubMed ID: 26186884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.